Changing CDMO Late in Development: What Biologics Teams Should Know

by 53Biologics

Changing CDMO late in development is not always a warning sign. Sometimes it is the right decision. But it should be managed as a strategic move, not an administrative transfer.

Read more

Curapath highlights its collaboration with Macro Biologics and celebrates the advancement of Amicidin α Surgical Gel toward Phase 1

by Curapath

Curapath is pleased to acknowledge the significant progress achieved by Macro Biologics, Inc., whose IND application for Amicidin‑α Surgical Gel has been accepted by the FDA, enabling the initiatio...

Read more

GENESIS Biomed contributes to the development of growth strategies for KYMOS and other Catalan companies through the NON ACCIÓ programme

by GENESIS Biomed

ACCIÓ’s Noves Oportunitats de Negoci calls for proposals provide Catalan companies with a supportive framework for analysing and structuring new growth opportunities.

Read more

Understanding the ADaM Framework for Data Analysis (Practical Guide for CROs and Sponsors)

by Sermes CRO

ADaM (Analysis Data Model) is the standard designed to ensure that analysis datasets are reproducible, reviewable, and traceable from tabulation (SDTM) to statistical results.

Read more

Building Trust Through Quality-Driven Clinical Solutions

by Pivotal

As the clinical research industry continues to grow, companies are facing increasing pressure to meet strict regulatory requirements while keeping studies moving efficiently. Sponsors today need depen...

Read more
Subscribe to Directory
Write an Article

Recent News

¿Por qué no es recomendable llevar la ...

La mejor actitud que podemos adoptar es la de trat...

Exposure to Heat and Cold During Pregnan...

The research team observed changes in head circumf...

Using mobile RNAs to improve Nitrogen a...

AtCDF3 gene induced greater production of sugars a...

Highlight

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

Telum Therapeutics Secures €18 Million...

by Telum Therapeutics

Telum Therapeutics, a biotechnology company leveraging proprietary met...

Photos Stream